Microarray analysis of global gene expression in leukocytes following lithium treatment

Human Psychopharmacology

Volumn 29, Issue 2, 2014, Pages 190-198

  Watanabe, Shinya ^a   Iga, Junichi ^a   Nishi, Akira ^a   Numata, Shusuke ^a   Kinoshita, Makoto ^a   Kikuchi, Kumiko ^a   Nakataki, Masahito ^a   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

gene expression; interleukin 6; leukocyte; lithium

Indexed keywords

ABELSON KINASE; APOLIPOPROTEIN; APOLIPOPROTEIN L6; BETA ACTIN; CELL SURFACE RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 KDA ALPHA (CYTOSOLIC) CLASS A MEMBER 1; INHIBITOR OF DIFFERENTIATION PROTEIN; INTERLEUKIN 6; LITHIUM CHLORIDE; METHANE; MYELOPEROXIDASE; PEPTIDASE; PROTEIN C JUN; RADICAL S ADENOSYL METHIONINE DOMAIN CONTAINING 2; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TAU PROTEIN; TUMOR NECROSIS FACTOR; UBIQUITIN SPECIFIC PEPTIDASE 28; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 507; IL6 PROTEIN, HUMAN; LITHIUM DERIVATIVE; PEROXIDASE; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANQUILIZER;

ARTICLE; CELL KILLING; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENETIC ANALYSIS; GRANULOCYTE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; LEUKOCYTE COUNT; LITHIUM BLOOD LEVEL; LYMPHOCYTE COUNT; MALE; MICROARRAY ANALYSIS; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULUS; TREATMENT DURATION; UPREGULATION; BLOOD; DRUG EFFECTS; GENETICS; LEUKOCYTE; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TIME;

ANTIMANIC AGENTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTES; LITHIUM COMPOUNDS; MALE; METHANE; MICROARRAY ANALYSIS; PEROXIDASE; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS;

EID: 84895525304     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2381     Document Type: Article

References (20)

1. Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, Flicker L,. 2008. Homocysteine and depression in later life. Arch Gen Psychiatry 65: 1286-1294.
2. Andersen CL, Jensen JL, Orntoft TF,. 2004. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
3. Baker BJ, Akhtar LN, Benveniste EN,. 2009. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30: 392-400.
4. Boku S, Nakagawa S, Koyama T,. 2010. Glucocorticoids and lithium in adult hippocampal neurogenesis. Vitam Horm 82: 421-431.
5. Coppen A, Bolander-Gouaille C,. 2005. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 19: 59-65.
6. Dai M, Freeman B, Shikani HJ, et al,. 2012. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS One 7: e44117.
7. Green HF, Nolan YM,. 2012. Unlocking mechanisms in interleukin-1beta- induced changes in hippocampal neurogenesis - a role for GSK-3beta and TLX. Transl Psychiatry 2: e194.
8. Iga J, Ueno S, Ohmori T,. 2008. Molecular assessment of depression from mRNAs in the peripheral leukocytes. Ann Med 40: 336-342.
9. Jope RS, Bijur GN,. 2002. Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Mol Psychiatry 7 Suppl 1: S35-45.
10. Kikuchi K, Iga J, Tayoshi S, et al,. 2011. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder. Hum Psychopharmacol 26: 358-363.
11. Matsebatlela T, Gallicchio V, Becker R,. 2012. Lithium modulates cancer cell growth, apoptosis, gene expression and cytokine production in HL-60 promyelocytic leukaemia cells and their drug-resistant sub-clones. Biol Trace Elem Res 149: 323-330.
12. O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG,. 2007. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41: 326-331.
13. Padmos RC, Bekris L, Knijff EM, et al,. 2004. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 56: 476-482.
14. Padmos RC, Hillegers MH, Knijff EM, et al,. 2008. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65: 395-407.
15. Port M, Seidl C, Ruf CG, Riecke A, Meineke V, Abend M,. 2012. Reliable and sample saving gene expression analysis approach for diagnostic tool development. Health Phys 103: 159-168.
16. Serretti A, Drago A,. 2010. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms. Neuropsychobiology 62: 61-71.
17. Sun X, Young LT, Wang JF, et al,. 2004. Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology 29: 799-804.
18. Tzeng SF,. 2003. Inhibitors of DNA binding in neural cell proliferation and differentiation. Neurochem Res 28: 45-52.
19. Vaccarino V, Brennan ML, Miller AH, et al,. 2008. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 64: 476-483.
20. Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J,. 2009. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 722-726.